Decision 56/47

Noting the substantial counterpart contribution from the MDI manufacturing enterprises, the urgent need to complete the conversion of the MDI sector to non-CFC alternatives and the work undertaken by the Government of India, the Secretariat and the bilateral and implementing agencies, the Executive Committee decided to approve the national strategy for transition to non-CFC MDIs and plan for phase-out of CFCs in the manufacture of pharmaceutical MDIs in India at US $10,202,267 plus agency support costs of US $851,700 (US $2,000,000 plus agency support costs of US $230,000 for the Government of Italy; US $8,082,267 plus agency support costs of US $606,170 for UNDP; and US $120,000 plus agency support costs of US $15,600 for UNEP), on the understanding the Government of India would have flexibility in using the funding approved for eligible activities that it considered adequate to achieve the complete phase-out of CFCs in the MDI sector and in accordance with relevant decisions and guidelines of the Fund.